SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-015466
Filing Date
2024-05-09
Accepted
2024-05-09 08:00:14
Documents
14
Period of Report
2024-05-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pirs20240507_8k.htm   iXBRL 8-K 25776
  Complete submission text file 0001437749-24-015466.txt   160394

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pirs-20240507.xsd EX-101.SCH 3408
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20240507_def.xml EX-101.DEF 11806
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20240507_lab.xml EX-101.LAB 15857
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20240507_pre.xml EX-101.PRE 12021
17 EXTRACTED XBRL INSTANCE DOCUMENT pirs20240507_8k_htm.xml XML 2945
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 24928663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)